Attox Research Lab, a healthtech startup based in Chennai, has made significant strides in combating superbugs.
Innovative Device for Antibiotic Sensitivity
The startup has developed a rapid antibiotic sensitivity analysis device. This technology is designed to identify which antibiotics can effectively eliminate specific bacteria found in patient samples.
Speeding Up Diagnosis
- Traditional methods take between 24 to 78 hours for results.
- Attox's device reduces this time to just two hours.
Impact on Patient Care
This rapid analysis is crucial for timely treatment decisions, especially in cases where bacterial infections can escalate quickly.
Addressing the Superbug Crisis
As antibiotic resistance grows, the need for swift and accurate testing becomes increasingly vital. Attox's innovation aims to enhance the effectiveness of antibiotic treatments.
